Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline - Novartis
business 2026/03/20 06:28:38

Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline - Novartis

Source:Novartis.com
Author:None

None

Related Articles

After DOJ antitrust firing, Trump’s Washington is wide open for mergers - Semafor
business 2026/02/14 21:36:00

After DOJ antitrust firing, Trump’s Washington is wide open for mergers - Semafor

The populism of Trump’s campaign has lost out to a baseline loose-leash Republicanism. Was it ever …

Semafor.com
Read More
Costco rival launches expansion plans - thestreet.com
business 2026/01/17 15:47:00

Costco rival launches expansion plans - thestreet.com

As shoppers seek out new ways to save money on groceries, Costco may have to pivot.

TheStreet
Read More
FCC green-lights Nexstar's $6.2B merger with rival TV station owner Tegna - NBC News
business 2026/03/20 12:24:00

FCC green-lights Nexstar's $6.2B merger with rival TV station owner Tegna - NBC News

The Federal Communications Commission has signed off on broadcast station owner Nexstar’s $6.2 …

NBC News
Read More
Tariffs, flight cancellations, OpenAI's spending reset and more in Morning Squawk - CNBC
business 2026/02/23 13:29:41

Tariffs, flight cancellations, OpenAI's spending reset and more in Morning Squawk - CNBC

Here are five key things investors need to know to start the trading day.

CNBC
Read More